Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $222,759 - $283,815
5,300 Added 82.81%
11,700 $507,000
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $277,696 - $330,432
6,400 New
6,400 $324,000
Q4 2022

Feb 14, 2023

SELL
$37.12 - $46.52 $827,776 - $1.04 Million
-22,300 Reduced 87.45%
3,200 $121,000
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $931,770 - $1.24 Million
25,500 New
25,500 $1.13 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.